 | • レポートコード：MRC2303H108 • 出版社/出版日：360iResearch / 2022年10月11日 • レポート形態：英語、PDF、231ページ • 納品方法：Eメール（受注後2-3日） • 産業分類：医療機器 |
| Single User（1名利用、印刷可） | ￥732,452 (USD4,949) | ▷ お問い合わせ |
| Enterprise License（企業利用、印刷可） | ￥1,472,452 (USD9,949) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 360iResearch社の当調査レポートでは、2021年に187.8億ドルであった世界の自動無効化シリンジ市場規模が2022年に209.0億ドルとなり、今後は年平均11.43％成長して2027年までに359.7億ドルに達すると予測しています。当書は、自動無効化シリンジの世界市場について調査し、序論、調査方法、エグゼクティブサマリー、市場概要、市場インサイト、疾患別（感染症、炎症性/自己免疫疾患、ワクチン）分析、サイズ別（0.05ml、0.1ml、0.3ml、0.5ml、その他）分析、エンドユーザー別（外来手術センター、診断研究所、病院）分析、用途別（採血、薬物送達、ワクチン接種）分析、地域別（南北アメリカ、アメリカ、カナダ、ブラジル、アジア太平洋、日本、中国、インド、韓国、台湾、ヨーロッパ/中東/アフリカ、イギリス、ドイツ、フランス、ロシア、その他）分析、競争状況、企業情報など、以下の構成でまとめております。なお、当書には、AccuPoint、AdvaCare Pharma、AlShifa Medical Products Co.、AlShifa Medical Syringe Manufacturing Company、Arab Medical Equipment Company、Avapezeshk、Becton Dickinson & Company (BD)、Destroject、Duopross Meditech Corp.などの企業情報が含まれています。 ・序論 ・調査方法 ・エグゼクティブサマリー ・市場概要 ・市場インサイト ・世界の自動無効化シリンジ市場規模：疾患別 - 感染症における市場規模 - 炎症性/自己免疫疾患における市場規模 - ワクチンにおける市場規模 ・世界の自動無効化シリンジ市場規模：サイズ別 - 自動無効化シリンジ（0.05ml）の市場規模 - 自動無効化シリンジ（0.1ml）の市場規模 - 自動無効化シリンジ（0.3ml）の市場規模 - 自動無効化シリンジ（0.5ml）の市場規模 - 自動無効化シリンジ（その他サイズ）の市場規模 ・世界の自動無効化シリンジ市場規模：エンドユーザー別 - 外来手術センターにおける市場規模 - 診断研究所における市場規模 - 病院における市場規模 ・世界の自動無効化シリンジ市場規模：用途別 - 採血における市場規模 - 薬物送達における市場規模 - ワクチン接種における市場規模 ・世界の自動無効化シリンジ市場規模：地域別 - 南北アメリカの自動無効化シリンジ市場規模 アメリカの自動無効化シリンジ市場規模 カナダの自動無効化シリンジ市場規模 ブラジルの自動無効化シリンジ市場規模 ... - アジア太平洋の自動無効化シリンジ市場規模 日本の自動無効化シリンジ市場規模 中国の自動無効化シリンジ市場規模 インドの自動無効化シリンジ市場規模 韓国の自動無効化シリンジ市場規模 台湾の自動無効化シリンジ市場規模 ... - ヨーロッパ/中東/アフリカの自動無効化シリンジ市場規模 イギリスの自動無効化シリンジ市場規模 ドイツの自動無効化シリンジ市場規模 フランスの自動無効化シリンジ市場規模 ロシアの自動無効化シリンジ市場規模 ... - その他地域の自動無効化シリンジ市場規模 ・競争状況 ・企業情報 |
The Global Auto-disable Syringes Market size was estimated at USD 18.78 billion in 2021 and expected to reach USD 20.90 billion in 2022, and is projected to grow at a CAGR 11.43% to reach USD 35.97 billion by 2027.
Market Statistics:
The report provides market sizing and forecast across 7 major currencies – USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period.
Market Segmentation & Coverage:
This research report categorizes the Auto-disable Syringes to forecast the revenues and analyze the trends in each of the following sub-markets:
Based on Indication, the market was studied across Infectious Diseases, Inflammatory/Auto-Immune Diseases, and Vaccines.
Based on Size, the market was studied across 0.05 ml, 0.1 ml, 0.3 ml, 0.5 ml, 1 ml, 10 ml, 3 ml, and 5 ml.
Based on End-User, the market was studied across Ambulatory Surgical Centers, Diagnostic Laboratories, and Hospitals.
Based on Application, the market was studied across Blood Collection, Drug Delivery, and Vaccination.
Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.
Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.
Cumulative Impact of 2022 Russia Ukraine Conflict:
We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Auto-disable Syringes market considering the current update on the conflict and its global response.
Competitive Strategic Window:
The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.
FPNV Positioning Matrix:
The FPNV Positioning Matrix evaluates and categorizes the vendors in the Auto-disable Syringes Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.
Market Share Analysis:
The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.
Competitive Scenario:
The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.
Company Usability Profiles:
The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Auto-disable Syringes Market, including AccuPoint, AdvaCare Pharma, AlShifa Medical Products Co., AlShifa Medical Syringe Manufacturing Company, Arab Medical Equipment Company, Avapezeshk, Becton Dickinson & Company (BD), Destroject, Duopross Meditech Corp., Hamilton Syringes (Sigma-Aldrich), Hindustan Syringes and Medical Devices, Hunan Pingan Medical Device Technology Co.,Ltd., Injecto A/S, Iscon Surgicals Ltd, JMI Group, L.O.M. Medical International, Medis Medical, PT Oneject, Retractable Technologies, Inc., Sanavita Pharmaceuticals Gmbh, Shandong Zhushi Pharmaceutical Group Co.,Ltd, SRS Meditech Limited, Terumo Medical Corporation, Vogt Medical, and Zibo Eastmed Healthcare Products Co., Ltd..
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments
The report answers questions such as:
1. What is the market size and forecast of the Global Auto-disable Syringes Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Auto-disable Syringes Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Auto-disable Syringes Market?
4. What is the competitive strategic window for opportunities in the Global Auto-disable Syringes Market?
5. What are the technology trends and regulatory frameworks in the Global Auto-disable Syringes Market?
6. What is the market share of the leading vendors in the Global Auto-disable Syringes Market?
7. What modes and strategic moves are considered suitable for entering the Global Auto-disable Syringes Market?
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rising incidence of needle stick injuries and cross infection
5.1.1.2. Growing R&D activities in the field in the recent years
5.1.1.3. Stringent regulations by government for safety
5.1.2. Restraints
5.1.2.1. High cost of procurement and raw material
5.1.3. Opportunities
5.1.3.1. Increasing scope in mass application campaign
5.1.3.2. Vendor focus towards advancement and sustainability
5.1.4. Challenges
5.1.4.1. Supply challenges for AD syringes in private hospitals
5.2. Cumulative Impact of COVID-19
6. Auto-disable Syringes Market, by Indication
6.1. Introduction
6.2. Infectious Diseases
6.3. Inflammatory/Auto-Immune Diseases
6.4. Vaccines
7. Auto-disable Syringes Market, by Size
7.1. Introduction
7.2. 0.05 ml
7.3. 0.1 ml
7.4. 0.3 ml
7.5. 0.5 ml
7.6. 1 ml
7.7. 10 ml
7.8. 3 ml
7.9. 5 ml
8. Auto-disable Syringes Market, by End-User
8.1. Introduction
8.2. Ambulatory Surgical Centers
8.3. Diagnostic Laboratories
8.4. Hospitals
9. Auto-disable Syringes Market, by Application
9.1. Introduction
9.2. Blood Collection
9.3. Drug Delivery
9.4. Vaccination
10. Americas Auto-disable Syringes Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific Auto-disable Syringes Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam
12. Europe, Middle East & Africa Auto-disable Syringes Market
12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom
13. Competitive Landscape
13.1. FPNV Positioning Matrix
13.1.1. Quadrants
13.1.2. Business Strategy
13.1.3. Product Satisfaction
13.2. Market Ranking Analysis, By Key Player
13.3. Market Share Analysis, By Key Player
13.4. Competitive Scenario
13.4.1. Merger & Acquisition
13.4.2. Agreement, Collaboration, & Partnership
13.4.3. New Product Launch & Enhancement
13.4.4. Investment & Funding
13.4.5. Award, Recognition, & Expansion
14. Company Usability Profiles
14.1. AccuPoint
14.1.1. Business Overview
14.1.2. Key Executives
14.1.3. Product & Services
14.2. AdvaCare Pharma
14.2.1. Business Overview
14.2.2. Key Executives
14.2.3. Product & Services
14.3. AlShifa Medical Products Co.
14.3.1. Business Overview
14.3.2. Key Executives
14.3.3. Product & Services
14.4. AlShifa Medical Syringe Manufacturing Company
14.4.1. Business Overview
14.4.2. Key Executives
14.4.3. Product & Services
14.5. Arab Medical Equipment Company
14.5.1. Business Overview
14.5.2. Key Executives
14.5.3. Product & Services
14.6. Avapezeshk
14.6.1. Business Overview
14.6.2. Key Executives
14.6.3. Product & Services
14.7. Becton Dickinson & Company (BD)
14.7.1. Business Overview
14.7.2. Key Executives
14.7.3. Product & Services
14.8. Destroject
14.8.1. Business Overview
14.8.2. Key Executives
14.8.3. Product & Services
14.9. Duopross Meditech Corp.
14.9.1. Business Overview
14.9.2. Key Executives
14.9.3. Product & Services
14.10. Hamilton Syringes (Sigma-Aldrich)
14.10.1. Business Overview
14.10.2. Key Executives
14.10.3. Product & Services
14.11. Hindustan Syringes and Medical Devices
14.11.1. Business Overview
14.11.2. Key Executives
14.11.3. Product & Services
14.12. Hunan Pingan Medical Device Technology Co.,Ltd.
14.12.1. Business Overview
14.12.2. Key Executives
14.12.3. Product & Services
14.13. Injecto A/S
14.13.1. Business Overview
14.13.2. Key Executives
14.13.3. Product & Services
14.14. Iscon Surgicals Ltd
14.14.1. Business Overview
14.14.2. Key Executives
14.14.3. Product & Services
14.15. JMI Group
14.15.1. Business Overview
14.15.2. Key Executives
14.15.3. Product & Services
14.16. L.O.M. Medical International
14.16.1. Business Overview
14.16.2. Key Executives
14.16.3. Product & Services
14.17. Medis Medical
14.17.1. Business Overview
14.17.2. Key Executives
14.17.3. Product & Services
14.18. PT Oneject
14.18.1. Business Overview
14.18.2. Key Executives
14.18.3. Product & Services
14.19. Retractable Technologies, Inc.
14.19.1. Business Overview
14.19.2. Key Executives
14.19.3. Product & Services
14.20. Sanavita Pharmaceuticals Gmbh
14.20.1. Business Overview
14.20.2. Key Executives
14.20.3. Product & Services
14.21. Shandong Zhushi Pharmaceutical Group Co.,Ltd
14.21.1. Business Overview
14.21.2. Key Executives
14.21.3. Product & Services
14.22. SRS Meditech Limited
14.22.1. Business Overview
14.22.2. Key Executives
14.22.3. Product & Services
14.23. Terumo Medical Corporation
14.23.1. Business Overview
14.23.2. Key Executives
14.23.3. Product & Services
14.24. Vogt Medical
14.24.1. Business Overview
14.24.2. Key Executives
14.24.3. Product & Services
14.25. Zibo Eastmed Healthcare Products Co., Ltd.
14.25.1. Business Overview
14.25.2. Key Executives
14.25.3. Product & Services
15. Appendix
15.1. Discussion Guide
15.2. License & Pricing